Selvita S.A. Investor Relations Material

Selvita S.A. is active in the pharmaceutical and biotechnology sectors. The company specializes in providing integrated services that encompass a wide range of solutions to support drug discovery, regulatory studies, and research and development. Selvita offers comprehensive drug discovery support from the initial stages of target validation through to the preclinical research phase, including the development and validation of drug testing and bioanalytical methods. The organization works closely with various research institutes and universities primarily in Europe and the United States. Founded in 2007, Selvita employs a large team of professionals, including a significant proportion with PhD qualifications. The company is headquartered in Krakow, Poland, and its shares are listed on the Warsaw Stock Exchange.